This paper is in the following e-collection/theme issue:

RCTs - Protocols/Proposals (eHealth) (668) Cancer Survivorship (334) Hearing Impairment and Hearing Loss (87) Clinical Cancer Research (116) Chemotherapy and Side Effects Management (110) Neurology and Neurosciences (286)

Published on in Vol 14 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/71562, first published .
Comparative Study of the Quality of Life of Patients With Ototoxicity Due to Platinum-Based Chemotherapy, With Hearing Aid Versus Those Without: Study Protocol for a Randomized Pilot Study—The PROTOTOX Study

Comparative Study of the Quality of Life of Patients With Ototoxicity Due to Platinum-Based Chemotherapy, With Hearing Aid Versus Those Without: Study Protocol for a Randomized Pilot Study—The PROTOTOX Study

Comparative Study of the Quality of Life of Patients With Ototoxicity Due to Platinum-Based Chemotherapy, With Hearing Aid Versus Those Without: Study Protocol for a Randomized Pilot Study—The PROTOTOX Study

Authors of this article:

Romina Mastronicola1, 2 Author Orcid Image ;   Elise Kayser1 Author Orcid Image ;   Yolanda Fernandez1 Author Orcid Image ;   Gilles Dolivet1, 2 Author Orcid Image
Article Authors Cited by Tweetations Metrics

Romina Mastronicola   1, 2 , PhD ;   Elise Kayser   1 , MSPH ;   Yolanda Fernandez   1 , PhD ;   Gilles Dolivet   1, 2 , PhD

1 Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy, France

2 Centre de Recherche en Automatique de Nancy (CRAN), UMR 7039, CNRS, Université de Lorraine, Vandœuvre-lès-Nancy, France

Corresponding Author: